FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2889751570> ?p ?o ?g. }

• W2889751570 abstract "Dual antiplatelet therapy (DAPT) is the recommended preventative treatment for secondary ischaemic events, but increases the risk of bleeding, potentially affecting patients’ health-related quality-of-life (HRQoL). Varied utility decrements have been used in cost-effectiveness models assessing alternative DAPT regimens, but it is unclear which of these decrements are most appropriate. Therefore, we reviewed existing sources of utility decrements for bleeds in patients receiving DAPT and undertook primary research to estimate utility decrements through a patient elicitation exercise using vignettes and the EuroQol EQ-5D. MEDLINE, PubMed and references of included studies were searched. Primary research and decision analytic modelling studies reporting utility decrements for bleeds related to DAPT were considered. For the primary research study, 21 participants completed an elicitation exercise involving vignettes describing minor and major bleeds and the EQ-5D-3 L and EQ-5D-5 L. Utility decrements were derived using linear regression and compared to existing estimates. Four hundred forty-two citations were screened, of which 12 studies were included for review. Reported utility decrements ranged from − 0.002 to − 0.03 for minor bleeds and − 0.007 to − 0.05 for major bleeds. Data sources used to estimate the decrements, however, lacked relevance to our population group and few studies adequately reported details of their measurement and valuation approaches. No study completely adhered to reimbursement agency requirements in the UK according to the National Institute for Health and Care Excellence reference case. Our primary research elicited utility decrements overlapped existing estimates, ranging from − 0.000848 to − 0.00828 for minor bleeds and − 0.0187 to − 0.0621 for major bleeds. However, the magnitude of difference depended on the instrument, estimation method and valuation approach applied. Several sources of utility decrements for bleeds are available for use in cost-effectiveness analyses, but are of limited quality and relevance. Our elicitation exercise has derived utility decrements from a relevant patient population, based on standardised definitions of minor and major bleeding events, using a validated HRQoL instrument and have been valued using general population tariffs. We suggest that our utility decrements be used in future cost-effectiveness analyses of DAPT." @default.
• W2889751570 created "2018-09-27" @default.
• W2889751570 creator A5008059536 @default.
• W2889751570 creator A5032575274 @default.
• W2889751570 creator A5040953408 @default.
• W2889751570 creator A5056372307 @default.
• W2889751570 creator A5065547580 @default.
• W2889751570 creator A5073547501 @default.
• W2889751570 creator A5079012045 @default.
• W2889751570 date "2018-09-20" @default.
• W2889751570 modified "2023-10-10" @default.
• W2889751570 title "Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study" @default.
• W2889751570 cites W1977195220 @default.
• W2889751570 cites W1985372205 @default.
• W2889751570 cites W1990163182 @default.
• W2889751570 cites W1990166011 @default.
• W2889751570 cites W1993883684 @default.
• W2889751570 cites W1994222210 @default.
• W2889751570 cites W1994370396 @default.
• W2889751570 cites W2013564592 @default.
• W2889751570 cites W2022548920 @default.
• W2889751570 cites W2058025443 @default.
• W2889751570 cites W2062245141 @default.
• W2889751570 cites W2069901088 @default.
• W2889751570 cites W2071686284 @default.
• W2889751570 cites W2078960594 @default.
• W2889751570 cites W2084326703 @default.
• W2889751570 cites W2096782143 @default.
• W2889751570 cites W2099497296 @default.
• W2889751570 cites W2116457054 @default.
• W2889751570 cites W2122779695 @default.
• W2889751570 cites W2127448855 @default.
• W2889751570 cites W2128611498 @default.
• W2889751570 cites W2140501627 @default.
• W2889751570 cites W2143043034 @default.
• W2889751570 cites W2148127765 @default.
• W2889751570 cites W2157965763 @default.
• W2889751570 cites W2169387542 @default.
• W2889751570 cites W2224814273 @default.
• W2889751570 cites W2226146252 @default.
• W2889751570 cites W2237771865 @default.
• W2889751570 cites W2272467298 @default.
• W2889751570 cites W2343426002 @default.
• W2889751570 cites W2366835925 @default.
• W2889751570 cites W2431546415 @default.
• W2889751570 cites W2559816575 @default.
• W2889751570 cites W2580858561 @default.
• W2889751570 cites W2750119242 @default.
• W2889751570 cites W2765387912 @default.
• W2889751570 cites W2765440969 @default.
• W2889751570 cites W2807735767 @default.
• W2889751570 cites W4294215472 @default.
• W2889751570 doi "https://doi.org/10.1186/s12955-018-1019-3" @default.
• W2889751570 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6149200" @default.
• W2889751570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30236119" @default.
• W2889751570 hasPublicationYear "2018" @default.
• W2889751570 type Work @default.
• W2889751570 sameAs 2889751570 @default.
• W2889751570 citedByCount "18" @default.
• W2889751570 countsByYear W28897515702019 @default.
• W2889751570 countsByYear W28897515702020 @default.
• W2889751570 countsByYear W28897515702021 @default.
• W2889751570 countsByYear W28897515702022 @default.
• W2889751570 countsByYear W28897515702023 @default.
• W2889751570 crossrefType "journal-article" @default.
• W2889751570 hasAuthorship W2889751570A5008059536 @default.
• W2889751570 hasAuthorship W2889751570A5032575274 @default.
• W2889751570 hasAuthorship W2889751570A5040953408 @default.
• W2889751570 hasAuthorship W2889751570A5056372307 @default.
• W2889751570 hasAuthorship W2889751570A5065547580 @default.
• W2889751570 hasAuthorship W2889751570A5073547501 @default.
• W2889751570 hasAuthorship W2889751570A5079012045 @default.
• W2889751570 hasBestOaLocation W28897515701 @default.
• W2889751570 hasConcept C112930515 @default.
• W2889751570 hasConcept C126322002 @default.
• W2889751570 hasConcept C159110408 @default.
• W2889751570 hasConcept C160735492 @default.
• W2889751570 hasConcept C162324750 @default.
• W2889751570 hasConcept C17744445 @default.
• W2889751570 hasConcept C1862650 @default.
• W2889751570 hasConcept C199539241 @default.
• W2889751570 hasConcept C2778464720 @default.
• W2889751570 hasConcept C2779134260 @default.
• W2889751570 hasConcept C2779473830 @default.
• W2889751570 hasConcept C2779703844 @default.
• W2889751570 hasConcept C2779951463 @default.
• W2889751570 hasConcept C2908647359 @default.
• W2889751570 hasConcept C3019006561 @default.
• W2889751570 hasConcept C3019080777 @default.
• W2889751570 hasConcept C50522688 @default.
• W2889751570 hasConcept C64332521 @default.
• W2889751570 hasConcept C71924100 @default.
• W2889751570 hasConcept C99454951 @default.
• W2889751570 hasConceptScore W2889751570C112930515 @default.
• W2889751570 hasConceptScore W2889751570C126322002 @default.
• W2889751570 hasConceptScore W2889751570C159110408 @default.
• W2889751570 hasConceptScore W2889751570C160735492 @default.
• W2889751570 hasConceptScore W2889751570C162324750 @default.
• W2889751570 hasConceptScore W2889751570C17744445 @default.
• W2889751570 hasConceptScore W2889751570C1862650 @default.

• next